Alzheimer's Disease/Cognition News

A plasma phosphorylated-tau217 assay demonstrated a high degree of accuracy in identifying biomarkers consistent with Alzheimer’s disease-related pathology, according to research from JAMA Neurology.

A Houston-area biotech company will expand indications of its investigational and proprietary biologic combination therapy beyond amyotrophic lateral sclerosis to include frontotemporal dementia and Parkinson’s disease.

More older patients with COPD, dementia or kidney failure had a palliative care consultation shortly after admission through a default ordering system vs. usual care, according to study results published in JAMA.

IGC Pharma has announced that dosing has commenced at one of its sites participating in a phase 2b clinical trial of a combination therapy for agitation in dementia related to Alzheimer’s disease.

Daily multivitamin supplementation was linked to benefits in both memory and cognition, according to a study published in the American Journal of Clinical Nutrition.

“Is it all worth it?” reads the title of the Reddit post from an international medical graduate community. I wake up to these posts ever so frequently; I think to myself and slide the notification away.

The European Medicines Agency has approved enrollment for a phase 1/2a biomarker study to examine a once-daily, oral, brain penetrant mitochondrial stimulator to treat a range of neurological and neuromuscular conditions.

Hearing loss was linked to a higher risk for dementia, and this risk was greater among people who did not use a hearing aid than those who did, a recent study in JAMA Otolaryngology – Head and Neck Surgery found.

A clinical-stage biopharma firm announced it has been granted a U.S. patent expanding coverage of a novel oral therapy to treat various conditions associated with loss-of-function mutations of the gene encoding methyl-CpG binding protein.

Sleep fragmentation, rather than sleep duration or self-reported sleep quality, in early midlife was associated with worse executive function, fluency and cognition more than a decade later, according to research in Neurology.